Key Takeaways
- Clinical Bottom Line
- The Macroscopic Distinction
Clinical Bottom Line
| Endoscopic Feature | Ulcerative Colitis (UC) | Crohn’s Disease (CD) |
|---|---|---|
| Mucosal Distribution | Continuous, circumferential inflammation starting perfectly at the anal verge and marching proximally. | “Skip lesions”—areas of severe, deep ulceration interspersed directly next to perfectly healthy, normal appearing mucosa. |
| Ulcer Morphology | Superficial, granular, weeping micro-ulcerations. | Deep, linear, “bear-claw”, or aphthous ulcerations creating a cobblestone appearance. |
| Rectal Involvement | Universally involved (99% of cases). | Frequently spared; the rectum is completely normal. |
The Macroscopic Distinction
While histology ultimately confirms Inflammatory Bowel Disease (IBD), the endoscopist’s macroscopic documentation of the disease topography is the primary mechanism for differentiating between Ulcerative Colitis and Crohn’s disease. The therapeutic algorithms—specifically the decision to utilize focal surgical resection versus systemic advanced biologics—hinge almost entirely on whether the disease is continuous or scattered.
The Rules of Anatomical Sparing
Ulcerative Colitis is biologically restricted to the colon, and it must, by definition, involve the rectum. It advances upstream in a perfectly continuous sheet of inflammation. Finding severe pancolitis but discovering perfect, pristine, normal mucosa in the rectum immediately invalidates a UC diagnosis (unless the patient has heavily utilized topical steroid enemas). Crohn’s disease respects no anatomical boundaries; it can induce massive transmural “skip” ulcerations from the lips to the anus, with the terminal ileum serving as its most quintessential target zone, an area completely immune to classic UC.
Clinical guidelines summarized by the Gastroscholar Research Team. Last updated: 2026. This article is intended for physicians.
